Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Rituximab/glucocorticoids

Gastrointestinal bleeding and COVID-19 infection

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ma Q, et al. Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy. Clinical and Experimental Medicine 23 : 5337-5343, Dec 2023. Available from: URL: https://dx.doi.org/10.1007/s10238-023-01183-1 Ma Q, et al. Combination of rituximab and short-term glucocorticoids in the treatment of anti-phospholipase A2 receptor antibody positive idiopathic membranous nephropathy. Clinical and Experimental Medicine 23 : 5337-5343, Dec 2023. Available from: URL: https://​dx.​doi.​org/​10.​1007/​s10238-023-01183-1
Metadaten
Titel
Rituximab/glucocorticoids
Gastrointestinal bleeding and COVID-19 infection
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57815-1

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Antineoplastics

Case report

Lorazepam

Case report

Multiple drugs

Case report

Heparin/Warfarin

Case report

Prednisone